Searched for
TARCEVA
Alembic Pharma gets USFDA nod for cancer treatment drugThe company has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) fo...- Cipla's U-turn: Happily ever after?In a foes-turn-friends move announced on February 27, the Mumbai-based drug maker announced that it will partner Swiss biotech company Roch...
- Cipla weighs legal options after Delhi HC's patent rulingDrug major Cipla is exploring all legal options in the wake of Delhi High Court's ruling that it has infringed Swiss drug major Hoffman-La ...
- Delhi HC upholds Roche's patent claims on Tarceva against CiplaIn a statement to ET, Roche said it welcomed the decision of the court, which has upheld the patent covering erlotinib hydrochloride.
- Why SC ruling won't bring down drug pricesDespite the SC verdict, Indian generics makers won't be falling over each other to take on Big Pharma and launch cheaper versions of their ...
- Cipla’s patent win against Roche boosts hopes of generic drugmakersThe Delhi HC ruling favouring India’s second largest drugmaker Cipla has come as a shot in the arm for other generic makers who are fightin...
- Cipla wins cancer drug patent caseCipla says it has scored a "landmark" court win in a patent challenge launched by Switzerland's Roche Holding over its version of a lung-ca...
- Delhi High Court dismisses Roche's patent suit against CiplaThe Delhi HC dismissed Hoffmann-La Roche's suit accusing Cipla of infringing the Swiss company's patent for its lung cancer medicine Tarcev...
- Cipla has not infringed F Hoffman La-Roche's patent cancer drug: High CourtThe Delhi HC held that Indian pharma major Cipla has not infringed upon the patent right of Swiss drug co F Hoffman La-Roche on a cancer dr...
- Hoffman La Roche loses patent suit against Matrix PharmaceuticalsRoche has lost a patent infringement suit against Matrix Pharma to prohibit the Indian firm from selling its anti-cancer drug Tarceva.
- Court asks Matrix not to sell generic of Roche’s cancer drugThe Madras High Court (HC) has asked Hyderabad-based Matrix Laboratories not to make or sell the generic version of Swiss major Roche’s can...
- Cipla gets relief as SC rejects Roche pleaThe Supreme Court on Friday rejected Swiss drugmaker Roche’s petition to stop Indian firm Cipla from selling the generic version of its can...
- SC asks Roche not to pursue Cipla case until patent examinationThe Supreme Court (SC) has asked Swiss company Roche not to pursue the patent violation case against the generic version of Cipla’s anti-in...
- Roche sues Cipla over Valcyte patent breachSwiss major Roche has moved the Bombay High Court (HC) against domestic major Cipla for allegedly infringing both the patent and trademark ...
- Generic cos may not get nod to sell patented drugsGeneric companies may no longer get marketing approval for copies of those drugs which have got patent in India.
- HC restrains Cipla from exporting anti-cancer drugThe Delhi High Court on Tuesday restrained pharma major Cipla from exporting ‘Tarceva’ to those countries where Swiss company Hoffmann La R...
- HC restrains Cipla from exporting anti-cancer drugThe Delhi High Court today restrained pharma major Cipla from exporting 'Tarceva' to those countries where Swiss company Hoffmann La Roche ...
- Natco plans copy of Roche cancer drugSome more good news could be around the corner for cancer patients and healthcare groups campaigning for access to cheaper medicines. A sec...
- Cipla scores a generic win over RocheThe Delhi HC rejected an injunction plea by Swiss drug major Roche to prevent Cipla from manufacturing generic versions of anti-cancer drug...
- Delhi HC refuses relief to Swiss Company La Roche against CiplaThe Delhi High Court has refused to grant relief to Swiss pharma company Hoffmann La Roche, which sought restraining Cipla from manufacturi...
Load More
